BBLN.F のPS 比率は同業他社と比較してどうか。

BBLN.Fは、同業他社の平均 ( { 0 x) と比較したPrice-To-Sales比率 ( 0.8 x) に基づいて価値が高いといえます。

BBLN.F'のPS レシオは、US Healthcare Services 業界の他社と比較してどうか。

BBLN.Fは、 US Healthcare Services業界平均 (2.2x) (0 x) と比較したPrice-To-Sales比率 ( 2.2 x) に基づいて価値が高いといえます。

BBLN.F'のPS レシオとフェアPS レシオを比較すると？これは、会社の予想利益成長率、利益率、その他のリスク要因を考慮した予想PS レシオです。

評価分析のためのBBLN.FのPrice-To-Sales公正比率を計算するにはデータが不十分です。

BBLN.F 、その将来キャッシュフローを見たときの公正価格はいくらになるだろうか？この見積もりには、割引キャッシュフローモデルを使用します。

評価分析のためのBBLN.Fの公正価値を計算するためのデータが不十分です。

アナリストの12ヶ月の予想と、コンセンサス目標株価に対する統計的信頼性は？

価格予測を表示するにはデータが不十分です。

Babylon Holdings ( ) - 株価, ニュースと分析OTCPK:BBLN.F

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BBLN.F 株式概要

Babylon Holdings Limited operates as a digital healthcare company. 詳細

BBLN.F ファンダメンタル分析
スノーフレーク・スコア
評価	2/6
将来の成長	0/6
過去の実績	0/6
財務の健全性	2/6
配当金	0/6

リスク分析

マイナスの株主資本

過去5年間で収益は年間12.9%減少しました。

意味のある時価総額がありません ( $535K )

過去1年間で株主の希薄化は大幅に進んだ

+1 さらなるリスク

Babylon Holdings Limited 競合他社

InnovaQor

OTCPK:INQR

US$20.4k

SCWorx

NasdaqCM:WORX

US$5.6m

iSpecimen

NasdaqCM:ISPC

US$4.1m

Aclarion

NasdaqCM:ACON

US$1.8m

価格と性能

の歴代最高値、変動、値下がりまとめBabylon Holdings
過去の株価
現在の株価	US$0.021
52週高値	US$24.00
52週安値	US$0.01
ベータ	1.73
11ヶ月の変化	-73.71%
3ヶ月変化	-98.24%
1年変化	-99.90%
33年間の変化	n/a
5年間の変化	n/a
IPOからの変化	-99.99%

Recent updates

Babylon to execute 1-for-25 reverse share split

Nov 09

Babylon Holdings files to sell 145.89M Class A ordinary shares

Oct 17

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Sep 22

株主還元

	BBLN.F	US Healthcare Services	US 市場
7D	22.2%	7.3%	2.0%
1Y	-99.9%	14.5%	32.4%

業界別リターン: BBLN.F過去 1 年間で14.5 % の収益を上げたUS Healthcare Services業界を下回りました。

リターン対市場: BBLN.Fは、過去 1 年間で32.4 % のリターンを上げたUS市場を下回りました。

価格変動

Is BBLN.F's price volatile compared to industry and market?
BBLN.F volatility
BBLN.F Average Weekly Movement	75.3%
Healthcare Services Industry Average Movement	9.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.9%
10% least volatile stocks in US Market	3.1%

安定した株価: BBLN.Fの株価は過去 3 か月間にわたって変動しています。

時間の経過による変動: BBLN.Fの週次ボラティリティは、過去 1 年間で40%から75%に増加しました。

会社概要

設立	従業員	CEO（最高経営責任者	ウェブサイト
2013	1,895	Parsa Parsadoust	www.babylonhealth.com

Babylon Holdings Limited 基礎のまとめ

Babylon Holdings の収益と売上を時価総額と比較するとどうか。
BBLN.F 基礎統計学
時価総額	US$535.33k
収益（TTM）	-US$255.58m
売上高(TTM)	US$1.15b

0.0x

P/Sレシオ

0.0x

PER（株価収益率

BBLN.F は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
BBLN.F 損益計算書（TTM）
収益	US$1.15b
売上原価	US$1.15b
売上総利益	US$3.13m
その他の費用	US$258.71m
収益	-US$255.58m

直近の収益報告

Mar 31, 2023

次回決算日

該当なし

一株当たり利益（EPS）	-9.98
グロス・マージン	0.27%
純利益率	-22.14%
有利子負債／自己資本比率	-93.8%

BBLN.F の長期的なパフォーマンスは？

過去の実績と比較を見る

This company listing is no longer active

BBLN.F 株式概要

リスク分析

Babylon Holdings Limited 競合他社

OTCPK:INQR

US$20.4k

NasdaqCM:WORX

US$5.6m

NasdaqCM:ISPC

US$4.1m

NasdaqCM:ACON

US$1.8m

価格と性能

最新ニュース

Babylon Holdings Limited Filed for Bankruptcy

Babylon Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Babylon Holdings Limited Announces Board Changes

Babylon Holdings Limited announced that it expects to receive $34.5 million in funding from AlbaCore Capital LLP

First quarter 2023 earnings released: US$2.53 loss per share (vs US$5.94 loss in 1Q 2022)

Global Chief Medical Officer recently sold US$74k worth of stock

Recent updates

Babylon Holdings Limited Filed for Bankruptcy

Babylon Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Babylon Holdings Limited Announces Board Changes

Babylon Holdings Limited announced that it expects to receive $34.5 million in funding from AlbaCore Capital LLP

First quarter 2023 earnings released: US$2.53 loss per share (vs US$5.94 loss in 1Q 2022)

Global Chief Medical Officer recently sold US$74k worth of stock

Global Chief Medical Officer recently sold US$74k worth of stock

Consensus revenue estimates decrease by 16%, EPS upgraded

Full year 2022 earnings: EPS exceeds analyst expectations

Babylon Holdings Limited to Report Q4, 2022 Results on Mar 09, 2023

Babylon Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

Consensus estimates of losses per share improve by 10%

Price target decreased to US$2.10

High number of new and inexperienced directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

VNV (Cyprus) Limited Engages in Discussions with Babylon Holdings Limited

Babylon to execute 1-for-25 reverse share split

Babylon Holdings Limited announced that it has received $80 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited announced that it expects to receive $61.45 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited Announces Resignation of Yon Nuta as Chief Product Officer, Effective October 18, 2022

Babylon Holdings files to sell 145.89M Class A ordinary shares

Babylon Holdings Limited to Report Q3, 2022 Results on Nov 10, 2022

Babylon Holdings Reportedly to Sell Meritage IPA Assets in Early 2023

Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa & Asia Go-To-Market Team

Babylon Receives Share Price Notice from the New York Stock Exchange Due to Non-Compliance with NYSE Rule 802.01C

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Babylon Holdings Limited Announces Chief Financial Officer Changes

Babylon gets new CFO

Babylon Holdings Denies Acquisition Rumors

Babylon Holdings jumps after report of potential sale process

Second quarter 2022 earnings: EPS misses analyst expectations

Babylon Holdings Limited Provides Guidance for the Twelve Months Ending December 31, 2022

Babylon Holdings Limited Announces Executive Changes

Babylon Holdings Limited, Annual General Meeting, Sep 14, 2022

Babylon Holdings Limited to Report Q2, 2022 Results on Aug 09, 2022

Babylon Holdings Limited Provides Earnings Guidance for the Year 2022

Babylon +2%, expects $100M savings per year

Consensus revenue estimates increase by 11%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Babylon Holdings Limited Revises Revenue Guidance for the Year 2022

Price target decreased to US$7.30

High number of new and inexperienced directors

Babylon Holdings Limited to Report Q1, 2022 Results on May 12, 2022

Consensus forecasts updated

Full year 2021 earnings: Revenues in line with analyst expectations

No longer forecast to breakeven

Babylon Holdings Limited to Report Q4, 2021 Results on Mar 10, 2022

Babylon Holdings Limited Announces Resignation of Stacy Saal as Chief Operating Officer, Effective February 12, 2022

Babylon Holdings: A Virtual Value-Based Care Leader With Upside

Babylon Holdings Limited (NYSE:BBLN) acquired DayToDay Health.

Babylon Holdings Limited Increases Revenue Guidance for the Full-Year 2022

Forecast to breakeven in 2024

High number of new and inexperienced directors

Babylon Launches AI in Rwanda in Next Step Towards Digitising Healthcare in Rwanda

Third quarter 2021 earnings released: US$0.08 loss per share

株主還元

価格変動

会社概要

Babylon Holdings Limited 基礎のまとめ